M T Rondina1,2,3, M Freitag4, F G Pluthero5, W H A Kahr5,6, J W Rowley1, L W Kraiss1,7, Z Franks1, G A Zimmerman1,2, A S Weyrich1,2, H Schwertz1,4,7,8. 1. Molecular Medicine Program, University of Utah, Salt Lake City, UT, USA. 2. Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA. 3. Department of Internal Medicine, George E. Wahlen Salt Lake City VAMC, Salt Lake City, UT, USA. 4. Department of Immunology and Transfusion Medicine, University of Greifswald, Greifswald, Germany. 5. Program in Cell Biology, Research Institute, Hospital for Sick Children, Toronto, ON, Canada. 6. Departments of Paediatrics and Biochemistry, University of Toronto, Toronto, ON, Canada. 7. Division of Vascular Surgery, Department of Surgery, University of Utah, Salt Lake City, UT, USA. 8. Lichtenberg-Professor for Experimental Hemostasis, University of Greifswald, Greifswald, Germany.
Abstract
UNLABELLED: Essentials Platelets employ proteins/signaling pathways traditionally thought reserved for nuclear niche. We determined retinoic-acid-receptor alpha (RARα) expression and function in human platelets. RARα/actin-related protein-2/3 complex (Arp2/3) interact via non-genomic signaling in platelets. RARα regulates Arp2/3-mediated actin cytoskeletal dynamics and platelet spreading. SUMMARY: Background Platelets utilize proteins and pathways classically reserved for the nuclear niche. Methods We determined whether human platelets express retinoic-acid-receptor family members, traditionally thought of as nuclear transcription factors, and deciphered the function of RARα. Results We found that RARα is robustly expressed in human platelets and megakaryocytes and interacts directly with actin-related protein-2/3 complex (Arp2/3) subunit 5 (Arp2/3s5). Arp2/3s5 co-localized with RARα in situ and regulated platelet cytoskeletal processes. The RARα ligand all-trans retinoic acid (atRA) disrupted RARα-Arp2/3 interactions. When isolated human platelets were treated with atRA, rapid cytoskeletal events (e.g. platelet spreading) were inhibited. In addition, when platelets were cultured for 18 h in the presence of atRA, actin-dependent morphological changes (e.g. extended cell body formation) were similarly inhibited. Using in vitro actin branching assays, RARα and Arp2/3-regulated complex actin branch formation was demonstrated. Consistent with inhibition of cytoskeletal processes in platelets, atRA, when added to this branching assay, resulted in dysregulated actin branching. Conclusion Our findings identify a previously unknown mechanism by which RARα regulates Arp2/3-mediated actin cytoskeletal dynamics through a non-genomic signaling pathway. These findings have broad implications in both nucleated and anucleate cells, where actin cytoskeletal events regulate cell morphology, movement and division.
UNLABELLED: Essentials Platelets employ proteins/signaling pathways traditionally thought reserved for nuclear niche. We determined retinoic-acid-receptor alpha (RARα) expression and function in human platelets. RARα/actin-related protein-2/3 complex (Arp2/3) interact via non-genomic signaling in platelets. RARα regulates Arp2/3-mediated actin cytoskeletal dynamics and platelet spreading. SUMMARY: Background Platelets utilize proteins and pathways classically reserved for the nuclear niche. Methods We determined whether human platelets express retinoic-acid-receptor family members, traditionally thought of as nuclear transcription factors, and deciphered the function of RARα. Results We found that RARα is robustly expressed in human platelets and megakaryocytes and interacts directly with actin-related protein-2/3 complex (Arp2/3) subunit 5 (Arp2/3s5). Arp2/3s5 co-localized with RARα in situ and regulated platelet cytoskeletal processes. The RARα ligand all-trans retinoic acid (atRA) disrupted RARα-Arp2/3 interactions. When isolated human platelets were treated with atRA, rapid cytoskeletal events (e.g. platelet spreading) were inhibited. In addition, when platelets were cultured for 18 h in the presence of atRA, actin-dependent morphological changes (e.g. extended cell body formation) were similarly inhibited. Using in vitro actin branching assays, RARα and Arp2/3-regulated complex actin branch formation was demonstrated. Consistent with inhibition of cytoskeletal processes in platelets, atRA, when added to this branching assay, resulted in dysregulated actin branching. Conclusion Our findings identify a previously unknown mechanism by which RARα regulates Arp2/3-mediated actin cytoskeletal dynamics through a non-genomic signaling pathway. These findings have broad implications in both nucleated and anucleate cells, where actin cytoskeletal events regulate cell morphology, movement and division.
Authors: Hervé Falet; Karin M Hoffmeister; Ralph Neujahr; Joseph E Italiano; Thomas P Stossel; Frederick S Southwick; John H Hartwig Journal: Proc Natl Acad Sci U S A Date: 2002-12-03 Impact factor: 11.205
Authors: Hansjörg Schwertz; Sarah Köster; Walter H A Kahr; Noemi Michetti; Bjoern F Kraemer; David A Weitz; Robert C Blaylock; Larry W Kraiss; Andreas Greinacher; Guy A Zimmerman; Andrew S Weyrich Journal: Blood Date: 2010-01-19 Impact factor: 22.113
Authors: Robert A Campbell; Zechariah Franks; Anish Bhatnagar; Jesse W Rowley; Bhanu K Manne; Mark A Supiano; Hansjorg Schwertz; Andrew S Weyrich; Matthew T Rondina Journal: J Immunol Date: 2017-11-22 Impact factor: 5.422
Authors: Hansjörg Schwertz; Jesse W Rowley; Irina Portier; Elizabeth A Middleton; Neal D Tolley; Robert A Campbell; Alicia S Eustes; Karin Chen; Matthew T Rondina Journal: Autophagy Date: 2021-11-18 Impact factor: 13.391
Authors: Robert A Campbell; Hansjorg Schwertz; Eugenio D Hottz; Jesse W Rowley; Bhanu Kanth Manne; A Valance Washington; Robert Hunter-Mellado; Neal D Tolley; Miles Christensen; Alicia S Eustes; Emilie Montenont; Seema Bhatlekar; Cassandra H Ventrone; Beth D Kirkpatrick; Kristen K Pierce; Stephen S Whitehead; Sean A Diehl; Paul F Bray; Guy A Zimmerman; Yasuhiro Kosaka; Patricia T Bozza; Fernando A Bozza; Andrew S Weyrich; Matthew T Rondina Journal: Blood Date: 2019-02-05 Impact factor: 25.476